Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_C1FFB5BA2CB1
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk.
Journal
Annals of neurology
Author(s)
Marignier R., Durand-Dubief F., du Pasquier R., Vukusic S.
ISSN
1531-8249 (Electronic)
ISSN-L
0364-5134
Publication state
Published
Issued date
11/2016
Peer-reviewed
Oui
Volume
80
Number
5
Pages
791
Language
english
Notes
Publication types: Letter
Publication Status: ppublish
OAI-PMH
oai:serval.unil.ch:BIB_C1FFB5BA2CB1
DOI
10.1002/ana.24768
Pubmed
27554031
Create date
16/09/2016 10:52
Last modification date
20/08/2019 15:36
Usage data